Veritas Bio Gets European Patent on Delivery Technology | GenomeWeb

Veritas Bio said this week that the European Patent Office has granted the company a patent covering its nucleic acid-delivery technology.

The patent, granted on patent application No. 07873598.21401, is entitled "In Vivo Delivery of Nucleic Acids," and covers the transfection of nucleic acids into skin or muscle cells. A US patent application on the technology was recently issued a notice of allowance.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.